Chimeric Antigen Receptors for the Tumour Microenvironment.

Habib, Rosemary; Nagrial, Adnan; Micklethwaite, Kenneth; Gowrishankar, Kavitha

Habib, Rosemary; Nagrial, Adnan; Micklethwaite, Kenneth; Gowrishankar, Kavitha.

Afiliación

Habib R; Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
Nagrial A; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
Micklethwaite K; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia.
Gowrishankar K; Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.

Adv Exp Med Biol ; 1263: 117-143, 2020.

Article en En | MEDLINE | ID: mdl-32588326

Asunto(s)

Inmunoterapia Adoptiva; Neoplasias/terapia; Receptores Quiméricos de Antígenos; Microambiente Tumoral; Humanos; Neoplasias/inmunología; Linfocitos T/inmunología

Palabras clave

Adoptive cell therapy (ACT); CAR; Cancer; Checkpoint receptors/checkpoint inhibitors/programmed cell death 1 receptor; Chemokine/chemokine receptor; Chimeric antigen receptor; Genetic engineering; Immunotherapy; NK-CAR; Stroma; T-cell homing; T-cell therapy; Tumour immunology; Tumour metabolism; Tumour microenvironment (TME); Vasculature

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Microambiente Tumoral / Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Adv Exp Med Biol Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google